The determination of total and unbound midazolam in human plasma. A comparison of high performance liquid chromatography, gas chromatography and gas chromatography/mass spectrometry

Biomedical Chromatography - Tập 4 Số 1 - Trang 28-33 - 1990
J. X. de Vries1, J. Rudi1, I. Walter‐Sack1, R. Conradi2
1Abteilung für Klinische Pharmakologie, Medizinische Klinik der Universität, Bergheimer Strasse 58, 6900 Heidelberg
2Klinik für Anästhesiologie der Universität, Im Neuenheimer Feld 110, 6900 Heidelberg, FRG

Tóm tắt

Abstract

Midazolam concentrations in patients' plasma was determined after extraction with high performance liquid chromatography (HPLC), gas chromatography (GC) and gas chromatography/mass spectrometry (GC/MS). GC was selected for routine plasma assays in terms of selectivity, simplicity, precision, accuracy and sensitivity (0.02 μg/ml); HPLC analysis was less sensitive (0.1 μg/mL) than GC; GC/MS was used for analysis validation. Plasma protein binding of midazolam was determined by GC in patients' plasma after in vitro incubation with midazolam, ultrafiltration and extraction; 5% of the drug was unbound to plasma proteins. Midazolam distribution in lipoprotein fractions separated by ultracentrifugation of plasma obtained from patients on prolonged midazolam treatment was also assayed by GC.

Từ khóa


Tài liệu tham khảo

10.1038/clpt.1981.217

Amrein R., 1981, Arzneim. Forsch./ Drug Res., 31, 2202

10.1007/BF00547375

10.1111/j.1365-2125.1983.tb02271.x

10.2165/00003088-198611010-00002

de Vries J. X., 1987, 17th Steenbock Symposium Current advances in Vitamin K research. University of Wisconsin‐Madison, 31

Dixon R., 1982, Res. Commun. Chem. Pathol. Pharmacol., 37, 11

10.1016/S0378-4347(00)83039-X

10.2165/00003495-198428060-00002

10.1111/j.1365-2125.1983.tb02266.x

10.1097/00000542-198108000-00014

10.1097/00000542-198461010-00006

Ha H. R., 1988, Clin. Chem., 34, 676, 10.1093/clinchem/34.4.676

Heizmann P., 1981, Arzneim. Forsch./ Drug Res., 31, 2220

10.1002/jhrc.1240040604

10.1111/j.1365-2125.1983.tb02270.x

10.1002/bms.1200110607

Kohlmeier M., 1986, Arztl. Lab., 32, 46

Kohlmeier M., 1984, Clin. Chem., 30, 295, 10.1093/clinchem/30.2.295

10.1111/j.1365-2125.1989.tb03429.x

10.1016/S0378-4347(00)81670-9

10.1016/S0378-4347(00)82020-4

10.1097/00000542-198503000-00017

10.1016/S0378-4347(00)81742-9

10.1111/j.1365-2125.1989.tb03428.x

10.1007/BF00562804

10.1016/S0378-4347(00)81497-8

10.1016/S0378-4347(00)80272-8

10.1016/S0378-4347(00)80432-6

Vree T. B., 1981, Arzneim. Forsch./ Drug Res., 31, 2215

10.1007/BF00609184